EXPERIENCES WITH NEW ANTIRHEUMATIC DRUG IN PRACTICE

被引：0
作者：
ZIEGELMAYER, W [1 ]
机构：
[1] FACHARZT INNERE KRANKHEITEN, FRIEDRICH EBERT ANLAGE 39, 6 FRANKFURT MAIN, WEST GERMANY
来源：
MEDIZINISCHE WELT | 1974年 / 25卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：426 / 428
页数：3
相关论文
共 50 条
[41]   MECHANISM OF ACTION OF HYDROXYCHLOROQUINE AS AN ANTIRHEUMATIC DRUG [J].
FOX, RI .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1993, 23 (02) :82-91
[42]   WHAT IS A DISEASE MODIFYING ANTIRHEUMATIC DRUG [J].
HEPBURN, B .
JOURNAL OF RHEUMATOLOGY, 1988, 15 :40-42
[43]   Starting a disease modifying antirheumatic drug or a biologic agent in rheumatoid arthritis: Standards of practice for RA treatment [J].
Wolfe, F ;
Rehman, V ;
Lane, NE ;
Kremer, J .
JOURNAL OF RHEUMATOLOGY, 2001, 28 (07) :1704-1711
[44]   Clinical practice recommendations for the choice of the first disease modifying antirheumatic drug in very early rheumatoid arthritis [J].
Le Loët, X ;
Berthelot, JM ;
Cantagrel, A ;
Combe, B ;
Debandt, M ;
Fautrel, B ;
Flipo, RM ;
Lioté, F ;
Maillefert, JF ;
Meyer, O ;
Saraux, A ;
Wending, D ;
Guillemin, F .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 :289-289
[45]   EFFECT OF NEW ANTIRHEUMATIC DRUG ON INTERLEUKINS PRODUCTION FROM HUMAN MONONUCLEAR-CELLS [J].
TAKESHITA, K ;
SUGIMOTO, T ;
OTOMO, S ;
AKABOSHI, T ;
KASHIWAZAKI, S .
ARTHRITIS AND RHEUMATISM, 1992, 35 (09) :S309-S309
[46]   Stereoselective disposition and chiral inversion of KE-298, a new antirheumatic drug, in rats [J].
Yoshida, H ;
Kohno, Y ;
Endo, H ;
Ohmi, N ;
Fukushima, K ;
Suwa, T ;
Hayashi, M .
CHIRALITY, 1997, 9 (01) :22-28
[47]   Tedizolid: new data and experiences for clinical practice [J].
Salavert Lleti, Miguel ;
Garcia-Bustos, Victor ;
Morata Ruiz, Laura ;
Dafne Cabanero-Navalon, Marta .
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2021, 34 :22-25
[48]   EXPERIENCES WITH A NEW DEVELOPED POWDER IN DERMATOLOGICAL PRACTICE [J].
FRIDERICH, H .
MEDIZINISCHE WELT, 1978, 29 (16) :679-681
[49]   Training and practice for drug inspectors in China: experiences, challenges, and developments [J].
Sun, Jinyao ;
Guo, Lubo ;
Shi, Zhixiang ;
Wu, Fang ;
Zhang, Yongze .
FRONTIERS IN MEDICINE, 2025, 12
[50]   OUR EXPERIENCES WITH A NEW ANTICONVULSANT DRUG, CLONAZEPAM [J].
SALCMANOVA, Z ;
SCHWARTZOVA, K .
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1976, 41 (05) :549-549
12345